Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Response to Letter to the Editor From Zhang et al: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer".
Journal: The Journal of clinical endocrinology and metabolism
Published: March 17, 2025
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 05, 2024
Showing 1-2 of 2
Last Updated: 09/26/2026